Detection of IL1β Gene in Sudanese Patients with Gliomas Tumor in Khartoum state, Sudan
Abstract
Introduction: Gliomas are the most prevalent type of primary intracranial tumors, representing 80% of all brain neoplasms.In Sudan Brain tumors have been as leading cause of mortality among children and as thirdcausative death among young adults.World Health Organization (WHO) classification2021, categorized gliomas into lower-grades gliomas (LGG,grades II and III) andglioblastoma (GBM, grade IV).Gliomas are surrounded by pool of pro inflammatory cytokines, chemokine and growth factor, particularly review the tumorigenic effects of central nervous system one of this inflammatory cytokines is Interleukin-1ß (IL-1ß ) which play a crucial role in gliomas pathophysiology.
Aims of the study: This study aimed to amplify IL-1ß gene and detect -5511, rs371339015 and rs376341819 SNPs in gliomassubtypes among Sudanese patients using PCR and Sanger sequencing.
Material and methods: The study was conducted at the National Center for Neurological Sciences during the period from May to September 2022, Khartoum Sudan. From all gliomas patientsduring the above mentioned period, tissue samples were collected and processed for DNA extraction, PCR and further Sanger sequencing
Results: In this study, the most common affected agegroup was 31- 40 years, supratentorial location was seen in more than half of the patients and the astrocytoma grade 1 was detected in 80.9%.
In astrocytoma grades I, the most frequent mutation was C >A in 28.7% and A > C in 19%.
C>T mutation was present in gliomasgrade I, II and III.
Conclusions: In this study, C>T was the most encountered mutation in astrocytoma grades.
Key words: Interleukin-1ß, DNA, PCR
Keywords:
Interleukin-1ß, DNA, PCRDOI
https://doi.org/10.22270/jddt.v12i6-S.5825References
Morgan LL, The epidemiology of glioma in adults a state of the science review, Neuro-Oncology, 2015; 17(4):623-624. https://doi.org/10.1093/neuonc/nou358
Bray FJ, Ferlay, I Soerjomataram, RL Siegel, LA Torre, and A. Jemal,"Global cancer statistics GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries," CA: a Cancer Journal for Clinicians, 2018; 68(6):394-424 https://doi.org/10.3322/caac.21492
Siegel RL, KD Miller, HE Fuchs, and A Jemal, Cancer statistics, CA: a Cancer Journal for Clinicians, 2021; 71(1):7-33 https://doi.org/10.3322/caac.21654
Kapoor, M.and Gupta, V Astrocytoma.In Stat Pearls [Internet]. Stat Pearls Publishing 2021.
Chen, JC Chen, Y Lin, JH Wu, JM and Tseng, SH Resveratrol suppresses angiogenesis in gliomas: evaluation by color Doppler ultrasound. Anticancer research2014; 26(2A):1237-1245.
Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA (June). "Malignant glioma: genetics and biology of a grave matter". Genes & Development, 2001; 15(11):1311 https://doi.org/10.1101/gad.891601
Sparmann A, Bar-Sagi D , Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell , 2004; 6:447-458 https://doi.org/10.1016/j.ccr.2004.09.028
Tanaka Y, Furuta T, Suzuki S, Orito E, Yeo AE, et al. Impact of interleukin- 1beta genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan. J Infect Dis; 2003; (187):1822-1825 https://doi.org/10.1086/375248
Tian Z, Shen X, Feng H, Gao B IL-1 beta attenuates IFN-alpha betainduced antiviral activity and STAT1 activation in the liver: involvement of proteasome-dependent pathway. J Immunol 2000; (165):3959-3965 https://doi.org/10.4049/jimmunol.165.7.3959
Sharma V, Dixit D, Koul N, Mehta VS, Sen E .Ras regulates interleukin-1b-induced HIF-1alpha transcriptional activity in glioblastoma. J Mol Med 2011b; (89):123-136 https://doi.org/10.1007/s00109-010-0683-5
Benson, VS Kirichek, O Beral, V and Green J Menopausal hormone therapy and central nervous system tumor risk: Large UK prospective study and meta‐analysis. International journal of cancer, 2015; 136(10):2369-2377 https://doi.org/10.1002/ijc.29274
Howlader N, NA et al (eds). SEER Cancer Statistics Review, 2014; 1975 based on November 2016 SEER data submission. (National Cancer Institute, Bethesda, MD, 2017).
Siegel RL, Miller KD, Jemal A, Cancer Statistics,CA: a cancer journal for clinicians 2017; (67):7-30. https://doi.org/10.3322/caac.21387
Usinskiene J, U lyte A, Bjornerud A, VeniusJ, Katsaros VK, Rynkeviciene R, et al, (2016),
Weathers, SP de Groot, J. VEGF Manipulation in Glioblastoma. Oncology (2015)
Forman DFBray D Brewster, CG ombe M balawa, B Kohler, M Piñeros, et al Cancer Incidence in Five Continents, 2013; X (electronic version, IARC, Lyon )
Louis DN, A Perry, G Reifenberger et al., "The 2016 World Health Organization classification of tumors of the central nervous system: a summary," ActaNeuropathologica, 2016 https://doi.org/10.1007/s00401-016-1545-1
(6):803-820, .Schroder,K,;Tschopp, j. Inflammasomes. Cell 2010
Usinskiene J, U lyte A, Bjornerud A, VeniusJ, Katsaros VK, Rynkeviciene R, et al, 2016.
Weathers, SP, de Groot, J VEGF Manipulation in Glioblastoma Oncology (2015).
Jarosz, M Olbert, M Wyszogrodzka, G Młyniec, K Librowski, T Antioxidant and anti-inflammatoryeffects of zinc. Zinc-dependent NF-κBsignaling. Inflammopharmacology, 2017; (25):11-24. https://doi.org/10.1007/s10787-017-0309-4
Lopez-Castejon G and Brough D Understanding the mechanism of IL-1β secretion. Cytokine&Growth Factor Reviews, 2011;22(4): 189-195. DOI: 10.1016/j.cytogfr.(2011.10.001). https://doi.org/10.1016/j.cytogfr.2011.10.001
Franchi Qu, YL Nunez, G Dubyak, GR Nonclassical IL-1β Secretion Stimulated by P2X7 Receptors Is Dependent on Inflammasome Activation and Correlated with Exosome Release in Murine Macrophages. J. Immunol, 2007; (179):1913-1925 https://doi.org/10.4049/jimmunol.179.3.1913
Evavold CL, Ruan, JTan, Y Xia, SWu, H Kagan, JC,The Pore-Forming Protein Gasdermin D Regulates Interleukin-1 Secretion from Living Macrophages. Immunity, 2018; 48(35):44 https://doi.org/10.1016/j.immuni.2017.11.013
Dmitrieva-Posocco, O Dzutsev, A Posocco, DF Hou, VYuan, W Thovarai, V Mufazalov, IA Gunzer, M Shilovskiy, I Khaitov, MR Cell-Type-Specific Responses to Interleukin-1 Control Microbial Invasion and Tumor-Elicited Inflammation in Colorectal Cancer. Immunity, 2019; (50):166-180 https://doi.org/10.1016/j.immuni.2018.11.015
Wang F, ZhangY,Wang S, Zhang Y, WuD Zhang, C Gao Y, Liu XWang, W Zhang S IL1 genes polymorphism and the risk of renal cell carcinoma in Chinese Han population. Oncotarget. 2017; (8) 56021-56029 https://doi.org/10.18632/oncotarget.18715
Hong Wu, TY,Jia, LWu, JXia, J, Wang J, Hu,Q, Cheng B Modulation of IL-1β reprograms the tumor microenvironment to interrupt oral carcinogenesis,Sci. Rep, 2016;(6):20208 https://doi.org/10.1038/srep20208
Snoussi K, Strosberg AD, Bouaouina N, Ben-Ahmed, SChouchane, L Genetic variation in pro-inflammatory cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma. Eur. Cytokine Netw, 2005; (16):253-260
SchroderK, Tschopp, J The Inflammasomes. Cell, 2010; (140):821-832 https://doi.org/10.1016/j.cell.2010.01.040
Bent R, Moll L, Grabbe S, Bros M, Interleukin-1 Beta-A Friend or Foe in Malignancies Int. J Mol. Sci, 2018;(19):2155 https://doi.org/10.3390/ijms19082155
Jarosz M, Olbert M, Wyszogrodzka G, Młyniec K, Librowski T. Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-κB signaling. Inflammopharmacology, 2017; (25):11-24 https://doi.org/10.1007/s10787-017-0309-4
Schroder K, SagulenkoV, Zamoshnikova A, Richards AACridland, JA Irvine, K Stacey, KJ SweetMJ Acute lipopolysaccharide priming boosts inflammasome activation independently of inflammasome sensor induction. Immunobiology, 2012; (217):1325-1329 https://doi.org/10.1016/j.imbio.2012.07.020
Davis BK, WenH Ting, JPYThe inflammasome NLRs in immunity, inflammation, and associated diseases. Annu. Rev. Immunol; 2011 https://doi.org/10.1146/annurev-immunol-031210-101405
Al-Tahhan MA, Etewa RL, Behery MM, Association between circulating interleukin-1 beta (IL-1) levels and IL-1 C-511T polymorphism with cervical cancer risk in Egyptian.
Wang L, Zhang LF, Wu J, Xu S Xu, YY, Li, D, Lou, J, Liu, MF IL-1β-Mediated Repression of microRNA-101 Is Crucial for Inflammation-Promoted Lung Tumorigenesis. Cancer Res, 2014; (74):4720-4730 https://doi.org/10.1158/0008-5472.CAN-14-0960
Matanic D, Beg-Zec Z, Stojanovi'c, D Matakori'c, N Flego, V Milevoj-Ribic, F Cytokines in Patients with Lung Cancer. Scand. J. Immunol, 2003; (57):173-178 https://doi.org/10.1046/j.1365-3083.2003.01205.x
Schauer IG, Zhang J, Xing Z Guo, X Mercado-Uribe, I Sood, AK Huang, P Liu, J. Interleukin-1β Promotes Ovarian Tumorigenesis through a p53/NF-κB-Mediated Inflammatory Response in Stromal Fibroblasts. Neoplasia.2013; (15):409-420 https://doi.org/10.1593/neo.121228
Rodríguez-Berriguete G, Sanchez-Espiridion B,Cansino JR Olmedilla G, Martínez-Onsurbe, P, Sanchez-Chapado, M Paniagua, R Fraile, B Royuela, M Clinical significance of both tumor and stromal expression of components of the IL-1 and TNF-α signaling pathways in prostate cancer. Cytokine, 2013; (64):555-563 https://doi.org/10.1016/j.cyto.2013.09.003
Woolery KT Mohamed, M Linger RJ Dobrinski, KP Roman, JKruk, PA BRCA1 185delAG Mutation Enhances Interleukin-1β Expression in Ovarian Surface Epithelial Cells. BioMed Res. Int, 2015; (2015):1-11. https://doi.org/10.1155/2015/652017
Chang YW, Jang J Kim, NH Lee, JW Lee, HJ Jung, WW Dong, SH Kim, HJ Kim, BH Lee, JI et al. Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1 Cytokine in Korean patients with gastric cancer. Int. J. Cancer, 2005; (114): 465-471. https://doi.org/10.1002/ijc.20724
Published
Abstract Display: 527 
PDF Downloads: 426 PDF Downloads: 25 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.